<!-- Generated by pkgdown: do not edit by hand -->
<!DOCTYPE html>
<html lang="en">
  <head>
  <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">

<title>Summary for Pseudo Dual responses simulations, relative to a given pseudo DLE and efficacy model
(except the EffFlexi class model) — summary,PseudoDualSimulations-method • crmPack</title>

<!-- favicons -->
<link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
<link rel="apple-touch-icon" type="image/png" sizes="180x180" href="../apple-touch-icon.png" />
<link rel="apple-touch-icon" type="image/png" sizes="120x120" href="../apple-touch-icon-120x120.png" />
<link rel="apple-touch-icon" type="image/png" sizes="76x76" href="../apple-touch-icon-76x76.png" />
<link rel="apple-touch-icon" type="image/png" sizes="60x60" href="../apple-touch-icon-60x60.png" />

<!-- jquery -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script>
<!-- Bootstrap -->
<link href="https://cdnjs.cloudflare.com/ajax/libs/bootswatch/3.4.0/cerulean/bootstrap.min.css" rel="stylesheet" crossorigin="anonymous" />


<script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script>

<!-- bootstrap-toc -->
<link rel="stylesheet" href="../bootstrap-toc.css">
<script src="../bootstrap-toc.js"></script>

<!-- Font Awesome icons -->
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous" />
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous" />

<!-- clipboard.js -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script>

<!-- headroom.js -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script>

<!-- pkgdown -->
<link href="../pkgdown.css" rel="stylesheet">
<script src="../pkgdown.js"></script>




<meta property="og:title" content="Summary for Pseudo Dual responses simulations, relative to a given pseudo DLE and efficacy model
(except the EffFlexi class model) — summary,PseudoDualSimulations-method" />
<meta property="og:description" content="Summary for Pseudo Dual responses simulations, relative to a given pseudo DLE and efficacy model
(except the EffFlexi class model)" />
<meta property="og:image" content="https://github.com/roche/crmPack/logo.png" />


<meta name="robots" content="noindex">

<!-- mathjax -->
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script>

<!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->



  </head>

  <body data-spy="scroll" data-target="#toc">
    <div class="container template-reference-topic">
      <header>
      <div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">crmPack</a>
        <span class="version label label-danger" data-toggle="tooltip" data-placement="bottom" title="In-development version">1.0.9000</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li>
  <a href="../index.html">
    <span class="fas fa-home fa-lg"></span>
     
  </a>
</li>
<li>
  <a href="../reference/index.html">Reference</a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    Articles
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="../articles/rolling-crm.html">Rolling CRM Example</a>
    </li>
    <li>
      <a href="../articles/simulations.html">Simulation study example</a>
    </li>
  </ul>
</li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https://github.com/roche/crmPack">
    <span class="fa fa-github fa-lg"></span>
     
  </a>
</li>
      </ul>
      
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

      

      </header>

<div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>Summary for Pseudo Dual responses simulations, relative to a given pseudo DLE and efficacy model
(except the EffFlexi class model)</h1>
    <small class="dont-index">Source: <a href='https://github.com/roche/crmPack/blob/master/R/Simulations-methods.R'><code>R/Simulations-methods.R</code></a></small>
    <div class="hidden name"><code>summary-PseudoDualSimulations-method.Rd</code></div>
    </div>

    <div class="ref-description">
    <p>Summary for Pseudo Dual responses simulations, relative to a given pseudo DLE and efficacy model
(except the EffFlexi class model)</p>
    </div>

    <pre class="usage"><span class='co'># S4 method for PseudoDualSimulations</span>
<span class='fu'><a href='https://rdrr.io/r/base/summary.html'>summary</a></span><span class='op'>(</span>
  <span class='va'>object</span>,
  <span class='va'>trueDLE</span>,
  <span class='va'>trueEff</span>,
  targetEndOfTrial <span class='op'>=</span> <span class='fl'>0.3</span>,
  targetDuringTrial <span class='op'>=</span> <span class='fl'>0.35</span>,
  <span class='va'>...</span>
<span class='op'>)</span></pre>

    <h2 class="hasAnchor" id="arguments"><a class="anchor" href="#arguments"></a>Arguments</h2>
    <table class="ref-arguments">
    <colgroup><col class="name" /><col class="desc" /></colgroup>
    <tr>
      <th>object</th>
      <td><p>the <code><a href='PseudoDualSimulations-class.html'>PseudoDualSimulations</a></code> object we want to summarize</p></td>
    </tr>
    <tr>
      <th>trueDLE</th>
      <td><p>a function which takes as input a dose (vector) and returns the true probability (vector)
of DLE</p></td>
    </tr>
    <tr>
      <th>trueEff</th>
      <td><p>a function which takes as input a dose (vector) and returns the mean efficacy value(s) (vector).</p></td>
    </tr>
    <tr>
      <th>targetEndOfTrial</th>
      <td><p>the target probability of DLE that are used at the end of a trial. Default at 0.3.</p></td>
    </tr>
    <tr>
      <th>targetDuringTrial</th>
      <td><p>the target probability of DLE that are used during the trial. Default at 0.35.</p></td>
    </tr>
    <tr>
      <th>...</th>
      <td><p>Additional arguments can be supplied here for <code>trueDLE</code> and <code>trueEff</code></p></td>
    </tr>
    </table>

    <h2 class="hasAnchor" id="value"><a class="anchor" href="#value"></a>Value</h2>

    <p>an object of class <code><a href='PseudoDualSimulationsSummary-class.html'>PseudoDualSimulationsSummary</a></code></p>

    <h2 class="hasAnchor" id="examples"><a class="anchor" href="#examples"></a>Examples</h2>
    <pre class="examples"><span class='r-in'><span class='co'>##obtain the plot for the simulation results</span></span>
<span class='r-in'><span class='co'>##If DLE and efficacy responses are considered in the simulations</span></span>
<span class='r-in'><span class='co'>##Specified your simulations when no samples are used</span></span>
<span class='r-in'><span class='va'>data</span> <span class='op'>&lt;-</span> <span class='fu'><a href='DataDual-class.html'>DataDual</a></span><span class='op'>(</span>doseGrid<span class='op'>=</span><span class='fu'><a href='https://rdrr.io/r/base/seq.html'>seq</a></span><span class='op'>(</span><span class='fl'>25</span>,<span class='fl'>300</span>,<span class='fl'>25</span><span class='op'>)</span><span class='op'>)</span></span>
<span class='r-in'><span class='co'>##First for the DLE model </span></span>
<span class='r-in'><span class='co'>##The DLE model must be of 'ModelTox' (e.g 'LogisticIndepBeta') class </span></span>
<span class='r-in'><span class='va'>DLEmodel</span> <span class='op'>&lt;-</span> <span class='fu'><a href='LogisticIndepBeta.html'>LogisticIndepBeta</a></span><span class='op'>(</span>binDLE<span class='op'>=</span><span class='fu'><a href='https://rdrr.io/r/base/c.html'>c</a></span><span class='op'>(</span><span class='fl'>1.05</span>,<span class='fl'>1.8</span><span class='op'>)</span>,</span>
<span class='r-in'>                              DLEweights<span class='op'>=</span><span class='fu'><a href='https://rdrr.io/r/base/c.html'>c</a></span><span class='op'>(</span><span class='fl'>3</span>,<span class='fl'>3</span><span class='op'>)</span>,</span>
<span class='r-in'>                              DLEdose<span class='op'>=</span><span class='fu'><a href='https://rdrr.io/r/base/c.html'>c</a></span><span class='op'>(</span><span class='fl'>25</span>,<span class='fl'>300</span><span class='op'>)</span>,</span>
<span class='r-in'>                              data<span class='op'>=</span><span class='va'>data</span><span class='op'>)</span></span>
<span class='r-in'></span>
<span class='r-in'><span class='co'>##The efficacy model of 'ModelEff' (e.g 'Effloglog') class </span></span>
<span class='r-in'><span class='va'>Effmodel</span><span class='op'>&lt;-</span><span class='fu'><a href='Effloglog.html'>Effloglog</a></span><span class='op'>(</span>Eff<span class='op'>=</span><span class='fu'><a href='https://rdrr.io/r/base/c.html'>c</a></span><span class='op'>(</span><span class='fl'>1.223</span>,<span class='fl'>2.513</span><span class='op'>)</span>,Effdose<span class='op'>=</span><span class='fu'><a href='https://rdrr.io/r/base/c.html'>c</a></span><span class='op'>(</span><span class='fl'>25</span>,<span class='fl'>300</span><span class='op'>)</span>,</span>
<span class='r-in'>                    nu<span class='op'>=</span><span class='fu'><a href='https://rdrr.io/r/base/c.html'>c</a></span><span class='op'>(</span>a<span class='op'>=</span><span class='fl'>1</span>,b<span class='op'>=</span><span class='fl'>0.025</span><span class='op'>)</span>,data<span class='op'>=</span><span class='va'>data</span><span class='op'>)</span></span>
<span class='r-in'></span>
<span class='r-in'><span class='co'>##The escalation rule using the 'NextBestMaxGain' class</span></span>
<span class='r-in'><span class='va'>mynextbest</span><span class='op'>&lt;-</span><span class='fu'><a href='NextBestMaxGain.html'>NextBestMaxGain</a></span><span class='op'>(</span>DLEDuringTrialtarget<span class='op'>=</span><span class='fl'>0.35</span>,</span>
<span class='r-in'>                            DLEEndOfTrialtarget<span class='op'>=</span><span class='fl'>0.3</span><span class='op'>)</span></span>
<span class='r-in'></span>
<span class='r-in'></span>
<span class='r-in'><span class='co'>##The increments (see Increments class examples) </span></span>
<span class='r-in'><span class='co'>## 200% allowable increase for dose below 300 and 200% increase for dose above 300</span></span>
<span class='r-in'><span class='va'>myIncrements</span><span class='op'>&lt;-</span><span class='fu'><a href='IncrementsRelative.html'>IncrementsRelative</a></span><span class='op'>(</span>intervals<span class='op'>=</span><span class='fu'><a href='https://rdrr.io/r/base/c.html'>c</a></span><span class='op'>(</span><span class='fl'>25</span>,<span class='fl'>300</span><span class='op'>)</span>,</span>
<span class='r-in'>                                 increments<span class='op'>=</span><span class='fu'><a href='https://rdrr.io/r/base/c.html'>c</a></span><span class='op'>(</span><span class='fl'>2</span>,<span class='fl'>2</span><span class='op'>)</span><span class='op'>)</span></span>
<span class='r-in'><span class='co'>##cohort size of 3</span></span>
<span class='r-in'><span class='va'>mySize</span><span class='op'>&lt;-</span><span class='fu'><a href='CohortSizeConst.html'>CohortSizeConst</a></span><span class='op'>(</span>size<span class='op'>=</span><span class='fl'>3</span><span class='op'>)</span></span>
<span class='r-in'><span class='co'>##Stop only when 36 subjects are treated</span></span>
<span class='r-in'><span class='va'>myStopping</span> <span class='op'>&lt;-</span> <span class='fu'><a href='StoppingMinPatients.html'>StoppingMinPatients</a></span><span class='op'>(</span>nPatients<span class='op'>=</span><span class='fl'>36</span><span class='op'>)</span></span>
<span class='r-in'><span class='co'>##Now specified the design with all the above information and starting with a dose of 25</span></span>
<span class='r-in'></span>
<span class='r-in'><span class='co'>##Specified the design(for details please refer to the 'DualResponsesDesign' example)</span></span>
<span class='r-in'><span class='va'>design</span> <span class='op'>&lt;-</span> <span class='fu'><a href='DualResponsesDesign.html'>DualResponsesDesign</a></span><span class='op'>(</span>nextBest<span class='op'>=</span><span class='va'>mynextbest</span>,</span>
<span class='r-in'>                              model<span class='op'>=</span><span class='va'>DLEmodel</span>,</span>
<span class='r-in'>                              Effmodel<span class='op'>=</span><span class='va'>Effmodel</span>,</span>
<span class='r-in'>                              stopping<span class='op'>=</span><span class='va'>myStopping</span>,</span>
<span class='r-in'>                              increments<span class='op'>=</span><span class='va'>myIncrements</span>,</span>
<span class='r-in'>                              cohortSize<span class='op'>=</span><span class='va'>mySize</span>,</span>
<span class='r-in'>                              data<span class='op'>=</span><span class='va'>data</span>,startingDose<span class='op'>=</span><span class='fl'>25</span><span class='op'>)</span></span>
<span class='r-in'><span class='co'>##Specify the true DLE and efficacy curves</span></span>
<span class='r-in'><span class='va'>myTruthDLE</span><span class='op'>&lt;-</span> <span class='kw'>function</span><span class='op'>(</span><span class='va'>dose</span><span class='op'>)</span></span>
<span class='r-in'><span class='op'>{</span> <span class='va'>DLEmodel</span><span class='op'>@</span><span class='va'>prob</span><span class='op'>(</span><span class='va'>dose</span>, phi1<span class='op'>=</span><span class='op'>-</span><span class='fl'>53.66584</span>, phi2<span class='op'>=</span><span class='fl'>10.50499</span><span class='op'>)</span></span>
<span class='r-in'><span class='op'>}</span></span>
<span class='r-in'></span>
<span class='r-in'><span class='va'>myTruthEff</span><span class='op'>&lt;-</span> <span class='kw'>function</span><span class='op'>(</span><span class='va'>dose</span><span class='op'>)</span></span>
<span class='r-in'><span class='op'>{</span><span class='va'>Effmodel</span><span class='op'>@</span><span class='va'>ExpEff</span><span class='op'>(</span><span class='va'>dose</span>,theta1<span class='op'>=</span><span class='op'>-</span><span class='fl'>4.818429</span>,theta2<span class='op'>=</span><span class='fl'>3.653058</span><span class='op'>)</span></span>
<span class='r-in'><span class='op'>}</span></span>
<span class='r-in'></span>
<span class='r-in'><span class='co'>## Then specified the simulations and generate the trial for 2 times</span></span>
<span class='r-in'><span class='va'>mySim</span> <span class='op'>&lt;-</span><span class='fu'><a href='https://rdrr.io/r/stats/simulate.html'>simulate</a></span><span class='op'>(</span>object<span class='op'>=</span><span class='va'>design</span>,</span>
<span class='r-in'>                 args<span class='op'>=</span><span class='cn'>NULL</span>,</span>
<span class='r-in'>                 trueDLE<span class='op'>=</span><span class='va'>myTruthDLE</span>,</span>
<span class='r-in'>                 trueEff<span class='op'>=</span><span class='va'>myTruthEff</span>,</span>
<span class='r-in'>                 trueNu<span class='op'>=</span><span class='fl'>1</span><span class='op'>/</span><span class='fl'>0.025</span>,</span>
<span class='r-in'>                 nsim<span class='op'>=</span><span class='fl'>2</span>,</span>
<span class='r-in'>                 seed<span class='op'>=</span><span class='fl'>819</span>,</span>
<span class='r-in'>                 parallel<span class='op'>=</span><span class='cn'>FALSE</span><span class='op'>)</span></span>
<span class='r-in'></span>
<span class='r-in'><span class='co'>##Then produce a summary of your simulations</span></span>
<span class='r-in'><span class='fu'><a href='https://rdrr.io/r/base/summary.html'>summary</a></span><span class='op'>(</span><span class='va'>mySim</span>,</span>
<span class='r-in'>        trueDLE<span class='op'>=</span><span class='va'>myTruthDLE</span>,</span>
<span class='r-in'>        trueEff<span class='op'>=</span><span class='va'>myTruthEff</span><span class='op'>)</span></span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Summary of 2 simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Target probability of DLE p(DLE) used at the end of a trial was 30 %</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The dose level corresponds to the target p(DLE) used at the end of a trial, TDEOT, was 152.6195 </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> TDEOT at dose Grid was 150 </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Target p(DLE) used during a trial was 35 %</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The dose level corresponds to the target p(DLE) used during a trial, TDDT, was 155.972 </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> TDDT at dose Grid was 150 </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Number of patients overall : mean 36 (36, 36) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Number of patients treated above the target p(DLE) used at the end of a trial : mean 6 (6, 6) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Number of patients treated above the target p(DLE) used during a trial : mean 6 (6, 6) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Proportions of observed DLT in the trials : mean 22 % (20 %, 24 %) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Mean toxicity risks for the patients : mean 21 % (20 %, 22 %) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Doses selected as TDEOT : mean 125 (125, 125) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> True toxicity at TDEOT : mean 5 % (5 %, 5 %) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Proportion of trials selecting the TDEOT: 0 %</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Proportion of trials selecting the TDDT: 0 %</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Dose most often selected as TDEOT: 125 </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Observed toxicity rate at dose most often selected: 7 %</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Fitted probabilities of DLE at dose most often selected : mean 23 % (21 %, 26 %) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The summary table of the final TDEOT across all simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>    137.6   143.9   150.2   150.2   156.5   162.8  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The summary table of the final ratios of the TDEOT across all simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>    2.206   2.209   2.212   2.212   2.215   2.218  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The summary table of the final TDDT across all simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>    155.6   162.5   169.3   169.3   176.2   183.1  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The summary table of dose levels, the optimal dose</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>  to recommend for subsequent study across all simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>    137.6   140.5   143.5   143.5   146.4   149.4  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The summary table of the final ratios of the optimal dose for stopping across</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>                   all simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>    2.206   2.606   3.006   3.006   3.406   3.806  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Target Gstar, the dose which gives the maximum gain value was 130.0097 </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Target Gstar at dose Grid was 125 </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The summary table of the final Gstar across all simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>    146.2   147.0   147.8   147.8   148.6   149.4  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The summary table of the final ratios of the Gstar across all simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>    3.799   3.801   3.802   3.802   3.804   3.806  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The summary table of dose levels, the optimal dose</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>  to recommend for subsequent study across all simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>    137.6   140.5   143.5   143.5   146.4   149.4  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The summary table of the final ratios of the optimal dose for stopping across</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>         all simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>    2.206   2.606   3.006   3.006   3.406   3.806  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Fitted expected efficacy level at dose most often selected : mean 1 (1, 1) </span>
<span class='r-in'><span class='co'>##If DLE and efficacy samples are involved</span></span>
<span class='r-in'><span class='co'>##Please refer to design-method 'simulate DualResponsesSamplesDesign' examples for details</span></span>
<span class='r-in'><span class='co'>##specified the next best</span></span>
<span class='r-in'><span class='va'>mynextbest</span><span class='op'>&lt;-</span><span class='fu'><a href='NextBestMaxGainSamples.html'>NextBestMaxGainSamples</a></span><span class='op'>(</span>DLEDuringTrialtarget<span class='op'>=</span><span class='fl'>0.35</span>,</span>
<span class='r-in'>                                   DLEEndOfTrialtarget<span class='op'>=</span><span class='fl'>0.3</span>,</span>
<span class='r-in'>                                   TDderive<span class='op'>=</span><span class='kw'>function</span><span class='op'>(</span><span class='va'>TDsamples</span><span class='op'>)</span><span class='op'>{</span></span>
<span class='r-in'>                                     <span class='fu'><a href='https://rdrr.io/r/stats/quantile.html'>quantile</a></span><span class='op'>(</span><span class='va'>TDsamples</span>,prob<span class='op'>=</span><span class='fl'>0.3</span><span class='op'>)</span><span class='op'>}</span>,</span>
<span class='r-in'>                                   Gstarderive<span class='op'>=</span><span class='kw'>function</span><span class='op'>(</span><span class='va'>Gstarsamples</span><span class='op'>)</span><span class='op'>{</span></span>
<span class='r-in'>                                     <span class='fu'><a href='https://rdrr.io/r/stats/quantile.html'>quantile</a></span><span class='op'>(</span><span class='va'>Gstarsamples</span>,prob<span class='op'>=</span><span class='fl'>0.5</span><span class='op'>)</span><span class='op'>}</span><span class='op'>)</span></span>
<span class='r-in'><span class='co'>##specified the design</span></span>
<span class='r-in'><span class='va'>design</span> <span class='op'>&lt;-</span> <span class='fu'><a href='DualResponsesSamplesDesign.html'>DualResponsesSamplesDesign</a></span><span class='op'>(</span>nextBest<span class='op'>=</span><span class='va'>mynextbest</span>,</span>
<span class='r-in'>                                     cohortSize<span class='op'>=</span><span class='va'>mySize</span>,</span>
<span class='r-in'>                                     startingDose<span class='op'>=</span><span class='fl'>25</span>,</span>
<span class='r-in'>                                     model<span class='op'>=</span><span class='va'>DLEmodel</span>,</span>
<span class='r-in'>                                     Effmodel<span class='op'>=</span><span class='va'>Effmodel</span>,</span>
<span class='r-in'>                                     data<span class='op'>=</span><span class='va'>data</span>,</span>
<span class='r-in'>                                     stopping<span class='op'>=</span><span class='va'>myStopping</span>,</span>
<span class='r-in'>                                     increments<span class='op'>=</span><span class='va'>myIncrements</span><span class='op'>)</span></span>
<span class='r-in'><span class='co'>##options for MCMC</span></span>
<span class='r-in'><span class='co'>##For illustration purpose, we will use 50 burn-ins to generate 200 samples</span></span>
<span class='r-in'><span class='va'>options</span><span class='op'>&lt;-</span><span class='fu'><a href='McmcOptions.html'>McmcOptions</a></span><span class='op'>(</span>burnin<span class='op'>=</span><span class='fl'>50</span>,step<span class='op'>=</span><span class='fl'>2</span>,samples<span class='op'>=</span><span class='fl'>200</span><span class='op'>)</span></span>
<span class='r-in'><span class='co'>##The simulations</span></span>
<span class='r-in'><span class='co'>##For illustration purpose only 2 simulation is produced (nsim=2). </span></span>
<span class='r-in'><span class='va'>mySim</span><span class='op'>&lt;-</span><span class='fu'><a href='https://rdrr.io/r/stats/simulate.html'>simulate</a></span><span class='op'>(</span><span class='va'>design</span>,</span>
<span class='r-in'>                args<span class='op'>=</span><span class='cn'>NULL</span>,</span>
<span class='r-in'>                trueDLE<span class='op'>=</span><span class='va'>myTruthDLE</span>,</span>
<span class='r-in'>                trueEff<span class='op'>=</span><span class='va'>myTruthEff</span>,</span>
<span class='r-in'>                trueNu<span class='op'>=</span><span class='fl'>1</span><span class='op'>/</span><span class='fl'>0.025</span>,</span>
<span class='r-in'>                nsim<span class='op'>=</span><span class='fl'>2</span>,</span>
<span class='r-in'>                mcmcOptions<span class='op'>=</span><span class='va'>options</span>,</span>
<span class='r-in'>                seed<span class='op'>=</span><span class='fl'>819</span>,</span>
<span class='r-in'>                parallel<span class='op'>=</span><span class='cn'>FALSE</span><span class='op'>)</span></span>
<span class='r-in'></span>
<span class='r-in'><span class='co'>##Then produce a summary of your simulations</span></span>
<span class='r-in'><span class='fu'><a href='https://rdrr.io/r/base/summary.html'>summary</a></span><span class='op'>(</span><span class='va'>mySim</span>,</span>
<span class='r-in'>        trueDLE<span class='op'>=</span><span class='va'>myTruthDLE</span>,</span>
<span class='r-in'>        trueEff<span class='op'>=</span><span class='va'>myTruthEff</span><span class='op'>)</span></span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Summary of 2 simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Target probability of DLE p(DLE) used at the end of a trial was 30 %</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The dose level corresponds to the target p(DLE) used at the end of a trial, TDEOT, was 152.6195 </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> TDEOT at dose Grid was 150 </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Target p(DLE) used during a trial was 35 %</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The dose level corresponds to the target p(DLE) used during a trial, TDDT, was 155.972 </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> TDDT at dose Grid was 150 </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Number of patients overall : mean 24 (14, 34) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Number of patients treated above the target p(DLE) used at the end of a trial : mean 3 (1, 5) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Number of patients treated above the target p(DLE) used during a trial : mean 3 (1, 5) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Proportions of observed DLT in the trials : mean 7 % (1 %, 12 %) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Mean toxicity risks for the patients : mean 10 % (2 %, 18 %) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Doses selected as TDEOT : mean 100 (20, 180) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> True toxicity at TDEOT : mean 44 % (9 %, 79 %) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Proportion of trials selecting the TDEOT: 0 %</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Proportion of trials selecting the TDDT: 0 %</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Dose most often selected as TDEOT: 0 </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Observed toxicity rate at dose most often selected: NaN %</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Fitted probabilities of DLE at dose most often selected : mean NA % (NA %, NA %) </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The summary table of the final TDEOT across all simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>    1.736  55.402 109.068 109.068 162.734 216.400  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The summary table of the final ratios of the TDEOT across all simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>       Min.   1st Qu.    Median      Mean   3rd Qu.      Max.  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>  1.520e+04 1.160e+16 2.320e+16 2.320e+16 3.481e+16 4.641e+16  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The summary table of the final TDDT across all simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>      Min.  1st Qu.   Median     Mean  3rd Qu.     Max.  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>    0.1401  75.4949 150.8497 150.8497 226.2045 301.5592  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The summary table of dose levels, the optimal dose</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>  to recommend for subsequent study across all simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>    1.736  55.402 109.068 109.068 162.734 216.400  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The summary table of the final ratios of the optimal dose for stopping across</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>                   all simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>       Min.   1st Qu.    Median      Mean   3rd Qu.      Max.  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>  1.520e+04 1.160e+16 2.320e+16 2.320e+16 3.481e+16 4.641e+16  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Target Gstar, the dose which gives the maximum gain value was 130.0097 </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Target Gstar at dose Grid was 125 </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The summary table of the final Gstar across all simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>      300     300     300     300     300     300  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The summary table of the final ratios of the Gstar across all simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     1.00    1.25    1.50    1.50    1.75    2.00  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The summary table of dose levels, the optimal dose</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>  to recommend for subsequent study across all simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>     Min. 1st Qu.  Median    Mean 3rd Qu.    Max.  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>    1.736  55.402 109.068 109.068 162.734 216.400  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> The summary table of the final ratios of the optimal dose for stopping across</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>         all simulations</span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>       Min.   1st Qu.    Median      Mean   3rd Qu.      Max.  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span>  1.520e+04 1.160e+16 2.320e+16 2.320e+16 3.481e+16 4.641e+16  </span>
<span class='r-out co'><span class='r-pr'>#&gt;</span> Fitted expected efficacy level at dose most often selected : mean NA (NA, NA) </span>
<span class='r-in'></span>
</pre>
  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">
    <nav id="toc" data-toggle="toc" class="sticky-top">
      <h2 data-toc-skip>Contents</h2>
    </nav>
  </div>
</div>


      <footer>
      <div class="copyright">
  <p>Developed by Daniel Sabanes Bove, Wai Yin Yeung, Giuseppe Palermo, Thomas Jaki, Jiawen Zhu, Ziwei Liao.</p>
</div>

<div class="pkgdown">
  <p>Site built with <a href="https://pkgdown.r-lib.org/">pkgdown</a> 1.6.1.</p>
</div>

      </footer>
   </div>

  


  </body>
</html>


